Middle East

Elsevier,

Overcoming Obstacles in Drug Discovery and Development, Surmounting the Insurmountable—Case Studies for Critical Thinking  2023

Racial and ethnic disparities among clinical trial participants is a long-standing issue demanding attention in the research community as advances in precision medicine increase. This exclusion from clinical trial enrollment has tangible consequences, preventing traditionally underserved populations from benefitting from health innovation and cutting-edge technologies. Aggregation of populations into a generalized treatment population lends to the evident healthcare inequities we see today and support SDG3
This Article supports SDGs 3 and 10 by assessing predictors for COVID-19 vaccine uptake among older Syrian refugees in Lebanon and highlighting the need to target hard to reach populations to improve access and uptake.
This study shows that agricultural water consumption tends to use internal water resources at a maximum level for export and national use, significantly impacting renewable and non-renewable water resource availability, especially in groundwater.
Elsevier,

One Health Meets the Exposome

Human, Wildlife, and Ecosystem Health

2023, Pages 150-189

Habitat conversion and resource utilization have been identified in the One Health approach as drivers of poor ecosystem health that can lead to disease spillover events supporting SDG3.
One Health and the Exposome embrace a broad view of human health and its environmental drivers as well as provide various tools and modes of operation to systematically uncover pathways linking poor health outcomes with their root causes to inform interventions supporting the WHO SDG3.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of gender-specific medicine in pharmaceutical development and global healthcare, aiming to improve health outcomes for all genders. By addressing the challenges faced by the pharmaceutical industry in integrating knowledge on sex-specific biological differences into drug development programs, the chapter advocates for strategies to promote equity in healthcare access and outcomes. Additionally, it recognizes the importance of addressing gender disparities in healthcare and advocating for approaches that ensure equal access to gender-specific pharmaceuticals. Through these efforts, the content supports the goal of reducing inequalities in healthcare access and outcomes, ultimately contributing to the promotion of good health and well-being for all individuals, regardless of gender.
Elsevier,

Translational Surgery

Handbook for Designing and Conducting Clinical and Translational Research

2023, Pages 591-597

The extensive history of abuse and ongoing mistreatment of Black Americans continues to foster apprehension and distrust of healthcare providers. This has resulted in substantial barriers for modern healthcare to appropriately address the needs of Black patients. These concerns have been visibly manifested during the COVID-19 pandemic. This article supports WHO SDG 3 Good Health and Wellbeing and SDG10 Reduced Inequalities.
Highlights the 21st century's fundamental “global health” reformulation of PubHealth and anticolonial resistance (to a perceived cultural imperialism of the West including in PubHealth) supporting SDG 3.
Elsevier,

Clinical Decision Support and Beyond (Third Edition)

Progress and Opportunities in Knowledge-Enhanced Health and Healthcare

2023, Pages 707-714

Clinical Decision support provides an effective tool to minimize many of the drivers of health disparities in healthcare. There is promising evidence that these tools can serve to promote equity across the healthcare spectrum supporting SDG 3. However, future iterations require a focus on equity from the start and inclusive and sustainable development, implementation, and evaluation practices.
The need and opportunities for global health strategies to leverage the power of digital health technology to improve healthcare outcomes are growing. Telehealth and other digital health products and services are becoming increasingly important in this effort, and methodical strategies should be used to evaluate the need, application, integration, maintenance, and scaling of such solutions. With the correct attention upon these areas, digital health can serve as a catalyst to improve healthcare outcomes and reduce disparities across the world, supporting SDG3.

Pages